デフォルト表紙
市場調査レポート
商品コード
1714632

造影剤市場:製品タイプ、画像診断法、剤型、投与経路、用途、エンドユーザー別-2025~2030年世界予測

Contrast Media Market by Product Type, Imaging Modality, Form, Route of Administration, Application, End User - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 199 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
造影剤市場:製品タイプ、画像診断法、剤型、投与経路、用途、エンドユーザー別-2025~2030年世界予測
出版日: 2025年04月01日
発行: 360iResearch
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

造影剤市場は、2024年には65億7,000万米ドルとなり、2025年にはCAGR 8.00%で70億8,000万米ドルに成長し、2030年には104億3,000万米ドルに達すると予測されています。

主要市場の統計
基準年 2024年 65億7,000万米ドル
推定年 2025年 70億8,000万米ドル
予測年 2030年 104億3,000万米ドル
CAGR(%) 8.00%

造影剤市場は、現代の画像診断の極めて重要なコンポーネントとして台頭し、さまざまな医療用途で画像の鮮明さと精度を高める重要な役割を担っています。このセグメントは、正確な診断手技と技術革新に対する需要の高まりに後押しされ、近年、製品の提供と応用手法が大きく進化しています。科学の進歩と規制の進歩が相まって、病気の発見、モニタリング、治療計画の立案を強化する画像診断技術の改善に道が開かれました。

技術的なブレークスルーは絶えず市場力学を再構築しており、化合物の製剤や投与方法の改善により、より安全で効果的な画像診断が可能となっています。世界の医療プロバイダは、こうした進歩を活用して、処置時間を短縮し、患者の安全性を向上させています。市場の成長の核心は、早期診断、精密医療、低侵襲的治療計画の重視にあります。

この変貌しつつあるセグメントを分析すると、研究機関から医療機器メーカーに至るまで、あらゆる利害関係者が技術革新と採用の推進に不可欠な役割を果たしていることが明らかになります。臨床ニーズと技術力の相互作用は、サステイナブル成長のための強固なプラットフォームを生み出します。早期診断に対する世界の意識の高まりと慢性疾患の有病率の上昇により、将来の展望は有望と考えられます。画像診断センターと病院の診断課題への取り組み方に革命をもたらすような、さらなる進歩がこの産業には控えています。この進化する物語は、現在と将来の市場情勢を形成する基本的動向、セグメンテーション力学、地域的影響、主要企業の貢献などを明らかにすることで、以降のセクションでより深く掘り下げるための舞台となります。

造影剤市場の変革

コントラストメディア産業は、強力な技術革新と規制基準の強化に牽引され、大きな変革期を迎えています。近年、従来の画像診断薬から、診断精度を高めるより特殊な製剤への移行が見られます。研究の進歩は分子イメージングにおけるブレークスルーをもたらし、生理学的プロセスの詳細な可視化を可能にしています。このような革新的なシフトは、臨床医に余分な小さな異常を特定する力を与え、それによって高リスク患者の早期発見に対する需要の高まりに応えています。

市場力学もまた、画像処理プロセスにおけるデジタル技術と自動化の統合によって再形成されています。画像診断における人工知能と機械学習の急速な導入により、データ分析が合理化され、解釈が改善されたため、画質と診断信頼性が向上しました。さらに、官民パートナーシップや国境を越えた協力関係の増加により、製品開発の加速化と世界の標準化が進み、規制枠組みの調和への道が開かれました。

さらに、慢性疾患の増加と相まって、進化する患者層は、優れた安全性プロファイルと有効性を提供する革新的な造影剤ソリューションを必要としています。新しい造影剤の性能向上が臨床検査で一貫して確認される中、市場各社は研究開発に多額の投資を続けており、競争的かつダイナミックな環境が醸成されています。この変革は、患者の予後を改善するだけでなく、進化し続ける医療の中で持続的な成長を目指す市場の姿勢を強化するものです。

市場セグメンテーション分析による主要な洞察

徹底的な市場セグメンテーション分析により、造影剤市場の多様な状況を明らかにする有意義な手段が明らかになりました。製品タイプ別に見ると、バリウム系造影剤、ガドリニウム系造影剤、ヨード系造影剤、マイクロバブル造影剤など、さまざまな製剤がさまざまな画像診断ニーズに対応しており、それぞれが診断精度に独自の優位性を持つ画像診断シナリオに合わせて設計されています。画像モダリティ別に見ると、CT(コンピュータ断層撮影)、MRI(磁気共鳴画像)、光イメージング、超音波、X線・蛍光透視の各セグメントに分かれ、技術ごとに需要が異なることが分かる。

さらに形態別に分類すると、市場は固定的なものではなく、動的なものであり、液体、ペースト、粉末の形態があり、それぞれが特定の臨床要件や患者プロファイルに適合していることがわかる。血管内投与、経口投与、直腸投与といった投与経路は、多様な患者のニーズやプロトコルに対応するためのカスタムソリューションを示しています。アプリケーションによるセグメンテーションは、造影剤の採用を促進する、がんや心血管疾患から消化器疾患、筋骨格系疾患、腎臓疾患、神経疾患まで、幅広い臨床症状を浮き彫りにします。さらに、外来手術センター、画像診断センター、病院などのエンドユーザーを考慮したセグメンテーションアプローチにより、さまざまな市場参入企業が専門的なニーズに基づいてサービス提供を最適化する方法を明確に理解することができます。この多層的なセグメンテーションは、市場の複雑性を反映し、消費者動向や目標とする製品イノベーションに関する重要な洞察を提供することで、利害関係者が情報に基づいた戦略的な意思決定を行うことを可能にします。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 診断画像を必要とする慢性疾患や病状の増加により、造影剤の必要性が高まっている
      • 医療施設における先進的画像技術の導入の増加により、造影剤の需要が高まっている
    • 抑制要因
      • 造影剤に関連する潜在的な副作用やアレルギー反応により、広範囲での使用が制限される
    • 機会
      • 造影剤製剤の技術的進歩により、安全性プロファイルが向上し、画像品質が向上し、新たな成長の展望が生まれている
      • 医療インフラと診断画像サービスの拡大により、新興市場では造影剤の使用が増加
    • 課題
      • 新しい造影剤製剤に対する規制上のハードルと承認プロセスにより、市場参入が遅れている
  • 市場セグメンテーション分析
    • 製品タイプ:ガドリニウムベースの造影剤の医療用画像における用途と利点
    • エンドユーザー:外来手術センターにおける造影剤の使用増加
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 法律
    • 環境

第6章 造影剤市場:製品タイプ別

  • イントロダクション
  • バリウム系造影剤
  • ガドリニウムベース造影剤
  • ヨウ素化造影剤
  • マイクロバブル造影剤

第7章 造影剤市場:画像診断法別

  • イントロダクション
  • コンピュータ断層撮影(CT)
  • 磁気共鳴画像法(MRI)
  • 光学イメージング
  • 超音波
  • X線検査と透視検査

第8章 造影剤市場:剤型別

  • イントロダクション
  • 液体
  • ペースト
  • 粉末

第9章 造影剤市場:投与経路別

  • イントロダクション
  • 血管内経路
  • 経口経路
  • 直腸経路

第10章 造影剤市場:用途別

  • イントロダクション
  • がん
  • 心血管疾患
  • 胃腸障害
  • 筋骨格系障害
  • 腎臓疾患
  • 神経疾患

第11章 造影剤市場:エンドユーザー別

  • イントロダクション
  • 外来手術センター
  • 診断画像センター
  • 病院

第12章 南北アメリカの造影剤市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第13章 アジア太平洋の造影剤市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第14章 欧州・中東・アフリカの造影剤市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第15章 競合情勢

  • 市場シェア分析、2024年
  • FPNVポジショニングマトリックス、2024年
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • Acro Lifesciences(I)Pvt. Ltd.
  • APOLLO RT Co. Ltd.
  • Bayer AG
  • Beijing Beilu Pharmaceutical Co., Ltd.
  • Bracco Spa
  • Covis Group
  • Daiichi Sankyo Co. Ltd.
  • Fuji Pharma Co. Ltd.
  • GE Healthcare
  • Guerbet SA
  • iMAX Diagnostic Imaging Limited
  • J. B. Chemicals & Pharmaceuticals Limited
  • Jodas Expoim Pvt. Ltd.
  • Lantheus Medical Imaging, Inc.
  • M.BIoTech Limited
  • MEDTRON AG
  • nanoPET Pharma GmbH
  • SANOCHEMIA Pharmazeutika GmbH
  • Spago Nanomedical AB
  • Trivitron Healthcare
  • ulrich GmbH & Co. KG
  • Vitalquan, LLC
図表

LIST OF FIGURES

  • FIGURE 1. CONTRAST MEDIA MARKET MULTI-CURRENCY
  • FIGURE 2. CONTRAST MEDIA MARKET MULTI-LANGUAGE
  • FIGURE 3. CONTRAST MEDIA MARKET RESEARCH PROCESS
  • FIGURE 4. CONTRAST MEDIA MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL CONTRAST MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. AMERICAS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 23. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 29. CONTRAST MEDIA MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CONTRAST MEDIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CONTRAST MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTRAST MEDIA MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTRAST MEDIA MARKET SIZE, BY BARIUM-BASED CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GADOLINIUM-BASED CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MICROBUBBLE CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTRAST MEDIA MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTRAST MEDIA MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTRAST MEDIA MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PASTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTRAST MEDIA MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTRAVASCULAR ROUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ORAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RECTAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEPHROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CONTRAST MEDIA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CONTRAST MEDIA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 287. CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 288. CONTRAST MEDIA MARKET, FPNV POSITIONING MATRIX, 2024
目次
Product Code: MRR-434CCDA04E9E

The Contrast Media Market was valued at USD 6.57 billion in 2024 and is projected to grow to USD 7.08 billion in 2025, with a CAGR of 8.00%, reaching USD 10.43 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 6.57 billion
Estimated Year [2025] USD 7.08 billion
Forecast Year [2030] USD 10.43 billion
CAGR (%) 8.00%

The contrast media market has emerged as a pivotal component of modern diagnostic imaging, providing critical enhancements to the clarity and precision of images across a range of medical applications. This sector, driven by increasing demand for accurate diagnostic procedures and technological innovations, has seen a significant evolution in product offerings and application methodologies over recent years. A combination of scientific advancement and regulatory progress has paved the way for improved imaging techniques that enhance disease detection, monitoring, and treatment planning.

Technological breakthroughs are continuously reshaping the market dynamics, with improvements in compound formulation and administration methods leading to safer and more effective imaging experiences. Global healthcare providers are capitalizing on these advances to reduce procedural times and improve patient safety. At its core, the market's growth is fueled by the emphasis on early diagnosis, precision medicine, and minimally invasive intervention planning.

As we analyze this transforming arena, it becomes clear that every stakeholder, from research institutions to medical device manufacturers, plays an integral role in driving innovation and adoption. The interplay of clinical needs with technological capabilities creates a robust platform for sustainable growth. With heightened global awareness about early diagnosis and the rising prevalence of chronic diseases, the future outlook appears promising. The industry is on the cusp of further advances that are likely to revolutionize how imaging centers and hospitals approach diagnostic challenges. This evolving narrative sets the stage for deeper explorations in subsequent sections, illuminating the underlying trends, segmentation dynamics, regional influences, and key corporate contributions that shape the current and future market landscape.

Transformative Shifts in the Contrast Media Landscape

The contrast media industry is undergoing significant transformation, driven by robust technological innovation and heightened regulatory standards. Recent years have witnessed a departure from conventional imaging agents towards more specialized formulations that offer enhanced diagnostic precision. Research advancements have led to breakthroughs in molecular imaging, enabling a detailed visualization of physiological processes. Such transformative shifts are empowering clinicians to identify extra-small anomalies, thereby catering to the growing demand for early detection in high-risk patients.

Market dynamics have also been reshaped by the integration of digital technologies and automation in imaging processes. The rapid adoption of artificial intelligence and machine learning in diagnostic imaging has streamlined data analysis and improved interpretation, thus enhancing image quality and diagnostic reliability. Additionally, an increasing number of public-private partnerships and cross-border collaborations have resulted in accelerated product development and global standardizations, paving the way for harmonized regulatory frameworks.

Furthermore, the evolving patient demographics coupled with a rise in chronic disease prevalence have necessitated innovative contrast media solutions that offer superior safety profiles and efficacy. With clinical trials consistently affirming the enhanced performance of new contrast agents, market players continue to invest heavily in research and development endeavors, fostering a competitive yet dynamic environment. This transformation not only catalyzes improved patient outcomes but also reinforces the market's commitment to sustainable growth amid an ever-evolving healthcare landscape.

Key Insights from Market Segmentation Analysis

A thorough segmentation analysis reveals meaningful avenues that delineate the diverse landscape of the contrast media market. A review of product type distinctions shows that various formulations cater to different imaging needs, including Barium-based Contrast Media, Gadolinium-based Contrast Media, Iodinated Contrast Media, and Microbubble Contrast Media, each designed for tailored imaging scenarios with their own advantages in diagnostic precision. When examining by imaging modality, the market splits its focus into Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Optical Imaging, Ultrasound, and X-Ray & Fluoroscopy, underscoring varied demand across different technologies.

Further stratification by form indicates that the market is not static; it is dynamic and incorporates liquid, paste, and powder formats-each adapted to specific clinical requirements and patient profiles. The route of administration, whether through intravascular routes, the oral route, or the rectal route, further exemplifies custom solutions to meet diverse patient needs and procedural protocols. Application-based segmentation highlights a wide array of clinical conditions that drive the adoption of contrast agents, ranging from cancer and cardiovascular diseases to gastrointestinal, musculoskeletal, nephrological, and neurological disorders. Moreover, considering end users such as ambulatory surgical centers, diagnostic imaging centers, and hospitals, the segmentation approach showcases a clear understanding of how different market players optimize their service delivery based on specialized needs. This multi-layered segmentation reflects the market's complexity and provides critical insights into consumer trends and targeted product innovation, thereby allowing stakeholders to make informed, strategic decisions.

Based on Product Type, market is studied across Barium-based Contrast Media, Gadolinium-based Contrast Media, Iodinated Contrast Media, and Microbubble Contrast Media.

Based on Imaging Modality, market is studied across Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Optical Imaging, Ultrasound, and X-Ray & Fluoroscopy.

Based on Form, market is studied across Liquid, Paste, and Powder.

Based on Route of Administration, market is studied across Intravascular Route, Oral Route, and Rectal Route.

Based on Application, market is studied across Cancer, Cardiovascular Diseases, Gastrointestinal Disorders, Musculoskeletal Disorders, Nephrological Disorders, and Neurological Disorders.

Based on End User, market is studied across Ambulatory Surgical Centers, Diagnostic Imaging Centers, and Hospitals.

Regional Trends Shaping the Global Contrast Media Market

Geographically, the growth trajectory and future potential of the contrast media market are significantly driven by regional trends. In the Americas, a robust healthcare infrastructure combined with advanced diagnostic facilities has fostered a conducive environment for the rapid adoption of new contrast media agents, ensuring high returns on innovation investments. In the region spanning Europe, the Middle East & Africa, there is a deliberate move towards integrating comprehensive healthcare reforms with advanced imaging capabilities, paving the way for regulatory uniformity and technological progress.

Across Asia-Pacific, the market has exhibited remarkable dynamism with accelerated urbanization, rising healthcare awareness, and increased access to state-of-the-art diagnostic centers. The diverse healthcare landscape in these regions, marked by both developed and emerging markets, contributes to a broad spectrum of opportunities. This collective regional analysis provides strategic insights into tailoring solutions based on localized needs, ensuring relevance and efficacy across global markets.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insights from Key Market Players in the Contrast Media Sector

The competitive landscape in the contrast media market is defined by a number of influential companies that lead in innovation and global outreach. Notable players include Acro Lifesciences (I) Pvt. Ltd., APOLLO RT Co. Ltd., Bayer AG, and Beijing Beilu Pharmaceutical Co., Ltd. Their contributions to product development, clinical research, and market penetration have been instrumental in setting industry benchmarks. Further, prominent companies such as Bracco Spa, Covis Group, Daiichi Sankyo Co. Ltd., among others, have continuously broadened their portfolios through targeted investments and strategic partnerships.

The participation of Fuji Pharma Co. Ltd., GE Healthcare, and Guerbet SA illustrates a deep commitment to advancing imaging technologies and enhancing the safety and efficacy of diagnostic procedures. The industry also benefits from efforts by firms like iMAX Diagnostic Imaging Limited and J. B. Chemicals & Pharmaceuticals Limited, who have carved niches in specialized segments. Additionally, contributions from Jodas Expoim Pvt. Ltd., Lantheus Medical Imaging, Inc., M.Biotech Limited, MEDTRON AG, nanoPET Pharma GmbH, SANOCHEMIA Pharmazeutika GmbH, Spago Nanomedical AB, Trivitron Healthcare, ulrich GmbH & Co. KG, and Vitalquan, LLC further enrich the competitive tapestry. These companies, distinguished by their extensive research capabilities, strong distribution networks, and customer-centric innovations, create a robust ecosystem that supports consistent market growth and addresses critical diagnostic needs through specialized contrast media solutions.

The report delves into recent significant developments in the Contrast Media Market, highlighting leading vendors and their innovative profiles. These include Acro Lifesciences (I) Pvt. Ltd., APOLLO RT Co. Ltd., Bayer AG, Beijing Beilu Pharmaceutical Co., Ltd., Bracco Spa, Covis Group, Daiichi Sankyo Co. Ltd., Fuji Pharma Co. Ltd., GE Healthcare, Guerbet SA, iMAX Diagnostic Imaging Limited, J. B. Chemicals & Pharmaceuticals Limited, Jodas Expoim Pvt. Ltd., Lantheus Medical Imaging, Inc., M.Biotech Limited, MEDTRON AG, nanoPET Pharma GmbH, SANOCHEMIA Pharmazeutika GmbH, Spago Nanomedical AB, Trivitron Healthcare, ulrich GmbH & Co. KG, and Vitalquan, LLC. Actionable Recommendations for Industry Leaders

Industry leaders must prioritize agility and continuous innovation to adapt to the rapidly changing contrast media landscape. It is crucial to invest in next-generation research for developing contrast agents that not only meet but exceed current safety and efficacy standards. Emphasizing collaboration across academic, clinical, and technological spheres can accelerate these advancements.

Leaders should incorporate strategic insights gained from segmentation and regional analyses to tailor product offerings and marketing strategies to specific market needs. Focusing on emerging regions with robust growth potential while leveraging established markets can balance risk with opportunity. Furthermore, companies are encouraged to streamline regulatory processes and establish proactive communication with healthcare authorities to expedite product approvals and market introduction.

Ultimately, enhancing cross-functional integration between research teams, marketing divisions, and sales channels will empower companies to navigate regulatory challenges more effectively and deliver solutions that resonate with end users. These targeted actions, rooted in data-driven insights and industry best practices, will foster sustainable growth and maintain competitive advantage in a rapidly evolving sector.

Conclusion: Navigating the Future of Contrast Media

The contrast media market is at a critical inflection point, where technological progress, enhanced safety standards, and evolving clinical demands converge to create a dynamic landscape ripe for innovation. Stakeholders across the value chain have an opportunity to harness cutting-edge research and tailored market strategies to drive the next wave of growth. Emphasis on precise segmentation, regional customization, and strategic corporate investments has laid a firm foundation for future developments. As the industry continues to advance, the ongoing dialogue between clinical needs and technological capabilities will be key to unlocking new levels of excellence in diagnostic imaging.

This comprehensive overview highlights the importance of adaptive strategies and proactive decision-making to meet the ever-changing needs of the healthcare ecosystem. By focusing on collaborative innovation and market-responsive strategies, industry leaders can secure not only competitive advantages but also improved patient outcomes and long-term success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases and medical conditions requiring diagnostic imaging fueling the need for contrast agents
      • 5.1.1.2. Increasing adoption of advanced imaging technologies in healthcare facilities driving the demand for contrast media
    • 5.1.2. Restraints
      • 5.1.2.1. Potential side effects and allergic reactions associated with contrast media limiting their widespread usage
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in contrast media formulations offering improved safety profiles and better imaging quality creating new growth prospects
      • 5.1.3.2. Growing use of contrast media in emerging markets due to the expansion of healthcare infrastructure and diagnostic imaging services
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory hurdles and approval processes for new contrast media formulations creating delays in market entry
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Applications and benefits of gadolinium-based contrast media in medical imaging
    • 5.2.2. End User: Growing use of contrast media in ambulatory surgical centers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Contrast Media Market, by Product Type

  • 6.1. Introduction
  • 6.2. Barium-based Contrast Media
  • 6.3. Gadolinium-based Contrast Media
  • 6.4. Iodinated Contrast Media
  • 6.5. Microbubble Contrast Media

7. Contrast Media Market, by Imaging Modality

  • 7.1. Introduction
  • 7.2. Computed Tomography (CT)
  • 7.3. Magnetic Resonance Imaging (MRI)
  • 7.4. Optical Imaging
  • 7.5. Ultrasound
  • 7.6. X-Ray & Fluoroscopy

8. Contrast Media Market, by Form

  • 8.1. Introduction
  • 8.2. Liquid
  • 8.3. Paste
  • 8.4. Powder

9. Contrast Media Market, by Route of Administration

  • 9.1. Introduction
  • 9.2. Intravascular Route
  • 9.3. Oral Route
  • 9.4. Rectal Route

10. Contrast Media Market, by Application

  • 10.1. Introduction
  • 10.2. Cancer
  • 10.3. Cardiovascular Diseases
  • 10.4. Gastrointestinal Disorders
  • 10.5. Musculoskeletal Disorders
  • 10.6. Nephrological Disorders
  • 10.7. Neurological Disorders

11. Contrast Media Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Diagnostic Imaging Centers
  • 11.4. Hospitals

12. Americas Contrast Media Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Contrast Media Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Contrast Media Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. FDA approval of innovative syringe-less MRI contrast media injector catalyzes efficiency and eco-friendliness
    • 15.3.2. Beilu Pharma's EU GMP certification paves the way for contrast media expansion into global markets
    • 15.3.3. GE HealthCare's advancement in safer MRI imaging with manganese-based contrast agent innovation
    • 15.3.4. Sanochemia's strategic roll-out of Resotran marks a shift towards gadolinium-free MRI contrast agents and enhanced liver diagnostics
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acro Lifesciences (I) Pvt. Ltd.
  • 2. APOLLO RT Co. Ltd.
  • 3. Bayer AG
  • 4. Beijing Beilu Pharmaceutical Co., Ltd.
  • 5. Bracco Spa
  • 6. Covis Group
  • 7. Daiichi Sankyo Co. Ltd.
  • 8. Fuji Pharma Co. Ltd.
  • 9. GE Healthcare
  • 10. Guerbet SA
  • 11. iMAX Diagnostic Imaging Limited
  • 12. J. B. Chemicals & Pharmaceuticals Limited
  • 13. Jodas Expoim Pvt. Ltd.
  • 14. Lantheus Medical Imaging, Inc.
  • 15. M.Biotech Limited
  • 16. MEDTRON AG
  • 17. nanoPET Pharma GmbH
  • 18. SANOCHEMIA Pharmazeutika GmbH
  • 19. Spago Nanomedical AB
  • 20. Trivitron Healthcare
  • 21. ulrich GmbH & Co. KG
  • 22. Vitalquan, LLC